Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Lucy Scientific Discovery, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
07/28/2023 8-K Quarterly results
07/07/2023 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...
Docs: "CONFIDENTIAL",
"Investor Contact:"
06/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp."
03/21/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "RECITALS A. The Seller is a business engaged in, among other things, the business of developing a novel therapy and proprietary protocol known as “SANA-013” for the treatment of Traumatic Brain Injury-related major depressive disorder . B. The Seller wishes to sell to the Buyer, and the Buyer wishes to purchase from the Seller, the assets of the Seller used solely in the Business, and in connection therewith the Buyer is willing to assume certain liabilities and obligations of the Seller relating thereto, all upon the terms and subject to the conditions set forth herein. AGREEMENT",
"Investor Contact:"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy